---
reference_id: "PMID:40448303"
title: "Underdiagnosis of Alpha-1 Antitrypsin Deficiency in Cirrhotic Liver Transplant Candidates: Findings From a Multicenter Retrospective Study."
authors:
- Evain M
- Ruiz I
- Antonini T
- Lassailly G
- Mazzola A
- Debry PH
- Elkrief L
- Anty R
- Sebagh M
- Ichai P
- Cherqui D
- Samuel D
- Kounis I
- Coilly A
- GREF 2 group
journal: Aliment Pharmacol Ther
year: '2025'
doi: 10.1111/apt.70183
content_type: abstract_only
---

# Underdiagnosis of Alpha-1 Antitrypsin Deficiency in Cirrhotic Liver Transplant Candidates: Findings From a Multicenter Retrospective Study.
**Authors:** Evain M, Ruiz I, Antonini T, Lassailly G, Mazzola A, Debry PH, Elkrief L, Anty R, Sebagh M, Ichai P, Cherqui D, Samuel D, Kounis I, Coilly A, GREF 2 group
**Journal:** Aliment Pharmacol Ther (2025)
**DOI:** [10.1111/apt.70183](https://doi.org/10.1111/apt.70183)

## Content

1. Aliment Pharmacol Ther. 2025 Jul;62(2):193-203. doi: 10.1111/apt.70183. Epub 
2025 May 30.

Underdiagnosis of Alpha-1 Antitrypsin Deficiency in Cirrhotic Liver Transplant 
Candidates: Findings From a Multicenter Retrospective Study.

Evain M(1), Ruiz I(2), Antonini T(3), Lassailly G(4), Mazzola A(5), Debry PH(6), 
Elkrief L(7), Anty R(8), Sebagh M(1), Ichai P(1), Cherqui D(1), Samuel D(1), 
Kounis I(1), Coilly A(1); GREF 2 group.

Author information:
(1)AP-HP Hôpital Paul Brousse, Centre Hépato-Biliaire, Paris-Saclay University, 
Villejuif, France.
(2)Department of Hepatology and Liver Transplantation, Centre Hospitalier de 
l'Universite of Montréal, Montreal, Canada.
(3)The Lyon liver institute, Everest IHU, Hepatology Department, Croix Rousse 
Hospital, Hospices Civils of Lyon, Lyon, France, Lyon, France.
(4)Service des Maladies de l'Appareil Digestif, Centre Hospitalier Universitaire 
de Lille (CHU de Lille), Lille, France; European Genomic Institute for Diabetes 
(EGID), UMR 1190 Translational Research for Diabetes, Inserm, CHU Lille, 
University of Lille, Lille, France.
(5)Service d'hépato-gastroentérologie, Hôpital La Pitié Salpêtrière, Paris, 
France.
(6)Service des maladies du foie, CHU Rennes, France.
(7)Faculté de médecine de Tours et CHRU de Tours, service 
d'hépato-gastroentérologie, centre de référence constitutif Maladies Vasculaires 
du foie, Filfoie, ERN Rare Liver, Tours, France.
(8)Archet 2 University hospital, Inserm U1065 team 8, université Côte d'Azur, 
Nice, France.

Erratum in
    Aliment Pharmacol Ther. 2025 Sep;62(6):676. doi: 10.1111/apt.70317.

BACKGROUND AND AIMS: Alpha-1 antitrypsin deficiency (AATD) is a prevalent 
genetic disorder in Europe causing hepatic fibrosis and often remains 
undiagnosed, even in severe cases requiring liver transplantation (LT). This 
study aimed to determine the frequency of pre-LT diagnosis amongst LT candidates 
with AATD and to describe their clinical characteristics. A secondary goal was 
to assess awareness and practices concerning AATD amongst LT specialists in 
France.
METHODS: This retrospective multicenter cohort study included LT candidates 
diagnosed with AATD based on PAS-positive staining of explanted livers 
(1995-2020) from nine centres in France and Canada. A 22-question survey was 
sent to LT specialists in France to assess AATD knowledge and practices.
RESULTS: Amongst 58 patients diagnosed with AATD between 1996 and 2020, 40% were 
diagnosed pre-LT, 15% post-LT and 45% never confirmed. Less than 25% had 
non-specific pulmonary symptoms. The survey revealed poor awareness of AATD; 78% 
of specialists rated their knowledge as very low to moderate. Consistent pre-LT 
screening occurred in 59.3% of cases, and 52.5% recommended familial screening 
upon a confirmed diagnosis.
CONCLUSION: AATD remains underdiagnosed in pre-LT assessments and is poorly 
understood amongst practitioners in France. Improved screening can enhance 
patient management, especially with emerging potentially curative treatments.

© 2025 The Author(s). Alimentary Pharmacology & Therapeutics published by John 
Wiley & Sons Ltd.

DOI: 10.1111/apt.70183
PMCID: PMC12203144
PMID: 40448303 [Indexed for MEDLINE]

Conflict of interest statement: The authors declare no conflicts of interest.